Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21410369 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Inner-City Anti-IgE Therapy for Asthma
Condition: Asthma
Interventions: Biological: omalizumab;   Biological: omalizumab placebo

Indicates status has not been verified in more than two years